These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3668521)

  • 1. Modification of dopamine and norepinephrine metabolism in the rat brain by monoamine oxidase inhibitors.
    Buu NT; Angers M; Duhaime J; Kuchel O
    J Neural Transm; 1987; 70(1-2):39-50. PubMed ID: 3668521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of monoamine oxidase inhibition: increased vesicular accumulation of dopamine and norepinephrine and increased metabolism by catechol-O-methyltransferase and phenolsulfotransferase.
    Buu NT; Lussier C
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):563-8. PubMed ID: 2748880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of vesicular dopamine and norepinephrine by monoamine oxidase inhibitors.
    Buu NT
    Biochem Pharmacol; 1989 May; 38(10):1685-92. PubMed ID: 2730683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between catechol-O-methyltransferase and phenolsulfotransferase in the metabolism of dopamine in the rat brain.
    Buu NT
    J Neurochem; 1985 Nov; 45(5):1612-9. PubMed ID: 3930664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
    Waldmeier PC; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
    Eisenhofer G; Finberg JP
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.
    Männistö PT; Tuomainen P
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):412-8. PubMed ID: 1766471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine produced from L-DOPA is degraded by endogenous monoamine oxidase in neurons of the dorsal raphe nucleus of the rat: an immunohistochemical study.
    Arai R; Karasawa N; Nagatsu I
    Brain Res; 1996 May; 722(1-2):181-4. PubMed ID: 8813364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo assessment of dopamine and norepinephrine release in rat neocortex: gas chromatography-mass spectrometry measurement of 3-methoxytyramine and normetanephrine.
    Wood PL; Kim HS; Altar CA
    J Neurochem; 1987 Feb; 48(2):574-9. PubMed ID: 3794722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of 3-methoxytyramine in rat brain by HPLC with electrochemical detection and its correlation with dopamine function after administration of a monoamine oxidase inhibitor and L-3,4-dihydroxyphenylalanine.
    Davies CL; Heal DJ
    J Neurochem; 1986 Dec; 47(6):1919-23. PubMed ID: 3772383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
    Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamine degradation by monoamine oxidase in locus coeruleus neurons of the rat. An immunohistochemical study.
    Kishimoto Y; Geffard M; Arai R
    Brain Res; 2000 Mar; 859(2):373-7. PubMed ID: 10719089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular accumulation of dopamine following L-DOPA administration.
    Buu NT
    Biochem Pharmacol; 1989 Jun; 38(11):1787-92. PubMed ID: 2735936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine sulfoconjugation in the rat brain: regulation by monoamine oxidase.
    Buu NT
    J Neurochem; 1985 Aug; 45(2):470-6. PubMed ID: 3925084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo.
    Kehr W
    J Neural Transm; 1981; 50(2-4):165-78. PubMed ID: 7241115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain.
    Heal DJ; Frankland AT; Buckett WR
    Neuropharmacology; 1990 Dec; 29(12):1141-50. PubMed ID: 2293058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR; Abercrombie ED
    J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T; Dong B; Ishii K; Kinemuchi H
    J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.